Found: 44
Select item for more details and to access through your institution.
Quadruplet therapy for newly diagnosed myeloma: comparative analysis of sequential cohorts with triplet therapy lenalidomide, bortezomib and dexamethasone (RVd) versus daratumamab with RVD (DRVd) in transplant-eligible patients.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01120-9
- By:
- Publication type:
- Article
The immune system in multiple myeloma and precursor states: Lessons and implications for immunotherapy and interception.
- Published in:
- American Journal of Hematology, 2023, v. 98, p. S4, doi. 10.1002/ajh.26752
- By:
- Publication type:
- Article
Myeloid neighborhood in myeloma: Cancer's underbelly?
- Published in:
- American Journal of Hematology, 2009, v. 84, n. 7, p. 395, doi. 10.1002/ajh.21460
- By:
- Publication type:
- Article
SARS-CoV-2 Vaccination in the First Year After Hematopoietic Cell Transplant or Chimeric Antigen Receptor T-Cell Therapy: A Prospective, Multicenter, Observational Study.
- Published in:
- Clinical Infectious Diseases, 2024, v. 79, n. 2, p. 542, doi. 10.1093/cid/ciae291
- By:
- Publication type:
- Article
Myeloma Immune and Antibody Targets.
- Published in:
- Clinical Lymphoma & Myeloma, 2009, v. 9, p. S18
- By:
- Publication type:
- Article
Harnessing CD1d-Restricted T Cells toward Antitumor Immunity in Humans.
- Published in:
- Annals of the New York Academy of Sciences, 2009, v. 1174, p. 61, doi. 10.1111/j.1749-6632.2009.04931.x
- By:
- Publication type:
- Article
Immune Response to Premalignancy Insights from Patients with Monoclonal Gammopathy.
- Published in:
- Annals of the New York Academy of Sciences, 2005, v. 1062, n. 1, p. 22, doi. 10.1196/annals.1358.004
- By:
- Publication type:
- Article
Game of Bones: How Myeloma Manipulates Its Microenvironment.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2020.625199
- By:
- Publication type:
- Article
Checkpoint Inhibition in Myeloma: Opportunities and Challenges.
- Published in:
- Frontiers in Immunology, 2018, p. N.PAG, doi. 10.3389/fimmu.2018.02204
- By:
- Publication type:
- Article
Immune Reconstitution and Vaccinations in Multiple Myeloma: A Report From the 19th International Myeloma Society Annual Workshop.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 6, p. 413, doi. 10.1016/j.clml.2023.03.009
- By:
- Publication type:
- Article
P-170: Transplant related morbidities with Melphalan as conditioning regimen for myeloma autotransplants.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S129, doi. 10.1016/S2152-2650(21)02297-7
- By:
- Publication type:
- Article
P-064: Heterogeneity of bone marrow biopsy and bone marrow aspirate (BMA) in patients with heavily pretreated relapsed/refractory Multiple Myeloma (RRMM).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S73, doi. 10.1016/S2152-2650(21)02198-4
- By:
- Publication type:
- Article
SOHO State of the Art Updates and Next Questions: T-Cell-Directed Immune Therapies for Multiple Myeloma: Chimeric Antigen Receptor-Modified T Cells and Bispecific T-Cell-Engaging Agents.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Clinical and Serologic Responses After a Two-dose Series of High-dose Influenza Vaccine in Plasma Cell Disorders: A Prospective, Single-arm Trial.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Syndecan-1 (CD138) Immunoreactivity in Bone Marrow Biopsies of Multiple Myeloma: Shed Syndecan-1 Accumulates in Fibrotic Regions.
- Published in:
- Modern Pathology, 2001, v. 14, n. 10, p. 1052, doi. 10.1038/modpathol.3880435
- By:
- Publication type:
- Article
Prophylactic tocilizumab to prevent cytokine release syndrome (CRS) with teclistamab: A single-center experience.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00963-y
- By:
- Publication type:
- Article
Eliminating the monitoring period with subcutaneous daratumumab: a single-center experience.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00801-1
- By:
- Publication type:
- Article
Eliminating the monitoring period with subcutaneous daratumumab: a single-center experience.
- Published in:
- 2023
- By:
- Publication type:
- Letter
Venetoclax ex vivo functional profiling predicts improved progression-free survival.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 8, p. 1, doi. 10.1038/s41408-022-00710-9
- By:
- Publication type:
- Article
Gain of Chromosome 1q is associated with early progression in multiple myeloma patients treated with lenalidomide, bortezomib, and dexamethasone.
- Published in:
- Blood Cancer Journal, 2019, v. 9, n. 12, p. 1, doi. 10.1038/s41408-019-0254-0
- By:
- Publication type:
- Article
Multiple myeloma immunoglobulin lambda translocations portend poor prognosis.
- Published in:
- Nature Communications, 2019, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41467-019-09555-6
- By:
- Publication type:
- Article
Bortezomib disrupts tumour--dendritic cell interactions in myeloma and lymphoma: therapeutic implications.
- Published in:
- British Journal of Haematology, 2007, v. 136, n. 1, p. 106, doi. 10.1111/j.1365-2141.2006.06369.x
- By:
- Publication type:
- Article
Severe and selective deficiency of interferon-γ-producing invariant natural killer T cells in patients with myelodysplastic syndromes.
- Published in:
- British Journal of Haematology, 2003, v. 122, n. 4, p. 617, doi. 10.1046/j.1365-2141.2003.04465.x
- By:
- Publication type:
- Article
Conditional overexpression of TGFβ1 promotes pulmonary inflammation, apoptosis and mortality via TGFβR2 in the developing mouse lung.
- Published in:
- Respiratory Research, 2015, v. 16, n. 1, p. 1, doi. 10.1186/s12931-014-0162-6
- By:
- Publication type:
- Article
Daratumumab in multiple myeloma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Survival outcomes of patients with primary plasma cell leukemia (pPCL) treated with novel agents.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Induction of Antigen-Specific Immunity with a Vaccine Targeting NY-ESO-1 to the Dendritic Cell Receptor DEC-205.
- Published in:
- Science Translational Medicine, 2014, v. 6, n. 232, p. 1, doi. 10.1126/scitranslmed.3008068
- By:
- Publication type:
- Article
Navigating the Fas lane to improved cellular therapy for cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Early B cell changes predict autoimmunity following combination immune checkpoint blockade.
- Published in:
- 2018
- By:
- Publication type:
- journal article
ABC transporters and NR4A1 identify a quiescent subset of tissue-resident memory T cells.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Cross center single-cell RNA sequencing study of the immune microenvironment in rapid progressing multiple myeloma.
- Published in:
- NPJ Genomic Medicine, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41525-022-00340-x
- By:
- Publication type:
- Article
Natural Killer T Cells in Cancer immunotherapy.
- Published in:
- Frontiers in Immunology, 2017, p. 1, doi. 10.3389/fimmu.2017.01178
- By:
- Publication type:
- Article
Dendritic Cells and Immunotherapy for Cancer.
- Published in:
- International Journal of Hematology, 2003, v. 77, n. 5, p. 439, doi. 10.1007/BF02986611
- By:
- Publication type:
- Article
Dendritic cells and immunotherapy for cancer.
- Published in:
- 2003
- By:
- Publication type:
- journal article
BA.5 bivalent booster vaccination enhances neutralization of XBB.1.5, XBB.1.16 and XBB.1.9 variants in patients with lung cancer.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00779-8
- By:
- Publication type:
- Article
TIM-3<sup>+</sup> CD8 T cells with a terminally exhausted phenotype retain functional capacity in hematological malignancies.
- Published in:
- Science Immunology, 2024, v. 9, n. 94, p. 1, doi. 10.1126/sciimmunol.adg1094
- By:
- Publication type:
- Article
Role of B cells in immune‐related adverse events following checkpoint blockade.
- Published in:
- Immunological Reviews, 2023, v. 318, n. 1, p. 89, doi. 10.1111/imr.13238
- By:
- Publication type:
- Article
Moving Immunoprevention Beyond Virally Mediated Malignancies: Do We Need to Link It to Early Detection?
- Published in:
- Frontiers in Immunology, 2019, p. 1, doi. 10.3389/fimmu.2019.02385
- By:
- Publication type:
- Article
Prognostic factors in elderly women with metastatic breast cancer treated with tamoxifen: an analysis of patients entered on four prospective clinical trials.
- Published in:
- 1996
- By:
- Publication type:
- journal article
Estrogen replacement therapy withdrawal and regression of metastatic breast cancer.
- Published in:
- 1995
- By:
- Publication type:
- journal article
Quantitation of circulating peripheral blood plasma cells and their relationship to disease activity in patients with multiple myeloma.
- Published in:
- 1993
- By:
- Publication type:
- journal article
Anti-myeloma activity of pamidronate in vivo.
- Published in:
- British Journal of Haematology, 1998, v. 103, n. 2, p. 530, doi. 10.1046/j.1365-2141.1998.00976.x
- By:
- Publication type:
- Article
Elevated levels of shed syndecan-1 correlate with tumour mass and decreased matrix metalloproteinase-9 activity in the serum of patients with multiple myeloma.
- Published in:
- British Journal of Haematology, 1997, v. 99, n. 2, p. 368, doi. 10.1046/j.1365-2141.1997.3893203.x
- By:
- Publication type:
- Article
Co-evolution of Immune Response in Multiple Myeloma: Implications for Immune Prevention.
- Published in:
- Frontiers in Immunology, 2021, v. 11, p. N.PAG, doi. 10.3389/fimmu.2021.632564
- By:
- Publication type:
- Article